Livingston Group Asset Management CO operating as Southport Capital Management Acquires 301 Shares of Humana Inc (NYSE:HUM)

Livingston Group Asset Management CO operating as Southport Capital Management raised its holdings in shares of Humana Inc (NYSE:HUM) by 14.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,407 shares of the insurance provider’s stock after buying an additional 301 shares during the period. Livingston Group Asset Management CO operating as Southport Capital Management’s holdings in Humana were worth $882,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of HUM. Commonwealth Equity Services LLC lifted its stake in shares of Humana by 3.0% in the 3rd quarter. Commonwealth Equity Services LLC now owns 11,569 shares of the insurance provider’s stock valued at $2,958,000 after acquiring an additional 337 shares during the last quarter. National Pension Service boosted its holdings in Humana by 5.0% during the 3rd quarter. National Pension Service now owns 163,520 shares of the insurance provider’s stock valued at $41,807,000 after acquiring an additional 7,730 shares during the period. Unigestion Holding SA boosted its holdings in Humana by 1.1% during the 3rd quarter. Unigestion Holding SA now owns 306,306 shares of the insurance provider’s stock valued at $78,313,000 after acquiring an additional 3,185 shares during the period. Virtu Financial LLC boosted its holdings in Humana by 123.3% during the 3rd quarter. Virtu Financial LLC now owns 3,823 shares of the insurance provider’s stock valued at $977,000 after acquiring an additional 2,111 shares during the period. Finally, Morgan Stanley boosted its holdings in Humana by 16.2% during the 2nd quarter. Morgan Stanley now owns 289,736 shares of the insurance provider’s stock valued at $76,866,000 after acquiring an additional 40,376 shares during the period. Institutional investors and hedge funds own 94.59% of the company’s stock.

In related news, insider Elizabeth D. Bierbower sold 400 shares of Humana stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $370.00, for a total transaction of $148,000.00. Following the completion of the transaction, the insider now directly owns 21,985 shares of the company’s stock, valued at approximately $8,134,450. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Timothy S. Huval sold 7,373 shares of the business’s stock in a transaction dated Friday, December 6th. The stock was sold at an average price of $348.60, for a total transaction of $2,570,227.80. Following the sale, the insider now directly owns 14,548 shares in the company, valued at approximately $5,071,432.80. The disclosure for this sale can be found here. Insiders have sold 45,294 shares of company stock worth $15,894,412 over the last 90 days. 0.54% of the stock is currently owned by corporate insiders.

HUM has been the subject of several analyst reports. Wells Fargo & Co restated an “overweight” rating and set a $400.00 target price (up from $338.00) on shares of Humana in a report on Wednesday, December 11th. Morgan Stanley restated a “buy” rating and set a $360.00 target price (up from $337.00) on shares of Humana in a report on Monday, November 18th. Mizuho initiated coverage on Humana in a report on Thursday, October 17th. They set a “buy” rating and a $316.00 target price for the company. ValuEngine cut Humana from a “buy” rating to a “hold” rating in a report on Wednesday, December 4th. Finally, Barclays increased their price objective on Humana from $327.00 to $358.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $355.75.

NYSE HUM traded up $0.69 on Thursday, hitting $364.76. The company’s stock had a trading volume of 156,075 shares, compared to its average volume of 828,475. Humana Inc has a 52-week low of $225.65 and a 52-week high of $376.39. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.46. The company’s 50-day simple moving average is $358.50 and its 200 day simple moving average is $304.25. The firm has a market cap of $47.31 billion, a P/E ratio of 25.07, a PEG ratio of 1.38 and a beta of 0.92.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 6th. The insurance provider reported $5.03 earnings per share for the quarter, topping the consensus estimate of $4.58 by $0.45. Humana had a return on equity of 22.32% and a net margin of 4.06%. The business had revenue of $16.24 billion during the quarter, compared to analysts’ expectations of $16.15 billion. During the same quarter last year, the business posted $4.58 EPS. The business’s revenue was up 14.3% on a year-over-year basis. On average, research analysts forecast that Humana Inc will post 17.77 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Monday, December 30th. This represents a $2.20 annualized dividend and a dividend yield of 0.60%. Humana’s dividend payout ratio is presently 15.12%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: What is the S&P/ASX 200 Index?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.